SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Chimera Investment Corporation (CIM) reported GAAP net income loss of $(4) million for Q2 2026, but maintained support for its $0.45 dividend as earni...
Cencora, Inc. filed an amendment to its $2.5 billion revolving credit agreement dated July 31, 2026. This refinancing significantly improves its debt ...
Kennametal reported a 43% increase in Q4 sales and record adjusted EPS in FY26, exceeding expectations. The company attributed growth to volume improv...
FTC Solar, Inc. signed a purchase agreement with Lincoln Park Capital Fund, LLC to sell up to $20 million of common stock....
Perrigo reported lower Q2 sales and margins but reaffirmed 2026 guidance, citing sequential improvement and portfolio streamlining via the sale of its...
NiSource beat non-GAAP EPS guidance for Q2 2026, confirming a $2.02-$2.07 EPS target and a $28.6 billion investment plan, despite net income falling y...
Delek Logistics reported Q2 2026 profit, raised guidance and continued distribution increases, reflecting operational strength across its crude and ga...
Institutional holdings report (13F-HR) filed by Y.D. More Investments Ltd....
Delek US reported strong second quarter 2026 results with a net income of $169.5 million. The company benefits from a high distillate yield and operat...
Institutional holdings report (13F-HR) filed by WILSON ASSET MANAGEMENT....
Freshpet reported 15.5% net sales growth and increased 2026 outlook, driven by lower input costs and expanding omnichannel presence, signaling strong ...
Total revenues slipped 2% in Q2 2026 to $783.3 million, while net income rose 8% to $333.0 million. The company highlighted record Tyvaso DPI growth a...
Cencora reported a 5.1% increase in Q3 2026 revenue to $84.8 billion and raised its adjusted diluted EPS guidance range to $17.75 to $17.95. Net incom...
Dynatrace reported a 17% increase in annual recurring revenue for Q1 FY27, beating revenue and profitability targets. The AI-focused observability pla...
CVS Health reported second-quarter 2026 revenues of $106.1 billion and raised its full-year GAAP adjusted EPS and cash flow guidance to reflect growth...
In Q2 2026, Bloomin' Brands reported diluted EPS of $0.37 and raised full-year guidance, citing progress from its Outback Turnaround strategy. The com...
Zimmer Biomet reported Q2 revenue growth of 4.8% and updated full-year 2026 guidance to reflect solid performance, while also increasing its share rep...
Elanco Animal Health reported second quarter 2026 results with revenue growth, raising full-year guidance and improving its net leverage ratio target ...
Institutional holdings report (13F-HR) filed by R Squared Ltd....
Santander Holdings USA Inc. and Webster Financial Corp. announced the completion of regulatory approvals for the pending transaction, with an expected...